A major review of clinical trials finds that tramadol, long viewed as a milder opioid for chronic pain, offers only modest relief while sharply raising the risk of serious side effects. Researchers now say its harms likely outweigh its benefits for many patients.
Top News:
5 Stoic Self Discipline Rules To Put Yourself First Without Feeling Selfish
The Art Of Self Reinvention: 8 Habits That Change Your Life From The Inside Out
Progress Over Perfection: How to Keep Going When You’re Not Motivated
12 Notes To Self You Should Remember Before The New Year
How Air Travel Will Change In 2026: Comfort, Costs And New Rules
Lebanese Cabinet Backs Financial Gap Law To Unlock Frozen Deposits
Silver Vs Nvidia: How A Metal Is Catching Up With The AI Giant
AI Boom Adds 500 Billion Dollars To US Tech Billionaires Net Worths
Groq Executives Join Nvidia In Strategic AI Chip Licensing Deal
Tramadol Under Fire: Study Says Popular Painkiller May Do More Harm Than Good
Why The Day After Christmas Is Often A Gift For Stock Market Investors
Scientists Reverse Advanced Alzheimer’s In Mice By Restoring Brain Energy Balance
Designing an Evening Routine That Helps You Actually Rest
Can NU-9 Stop Alzheimers Before It Starts? New Drug Shows Promise In Mice
Farewell to Walid Al Alayli, A Quiet Pillar of Lebanese Drama
How to Build Confidence Through Action (Not Just Positive Thinking)
Lebanon Senior Evyn Underwood Signs With Walters State Baseball
Athletes of the Week: Mt. Lebanon’s Liam Sheely and Greensburg Central Catholic’s Erica Gribble
The Gentle Guide to Morning Routines (For People Who Hate Mornings)
Home » BMJ review